IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer's Trial -January 17, 2024 at 09:21 am EST
- ClinCloud has dosed its first patient in trial investigating the safety and efficacy of IGC-AD1 on agitation in Alzheimer’s Disease - ...
Source: marketscreener.com